MMP9 and breast cancer: Another meta-analysis published by Han et.al corroborated this conclusion, indicating that MMP-9–1562 C/T polymorphism was a risk factor of BC, especially in European population whereas MMP2 polymorphism MMP-2–1306 C/T polymorphism was a protecting factor for BC in Asian population27.